Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.99 USD | +1.61% | +5.14% | -23.57% |
Apr. 23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
Apr. 22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.57% | 8.37B | |
+10.44% | 107B | |
+0.82% | 106B | |
+9.02% | 23.47B | |
-13.89% | 21.9B | |
-6.17% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Transcript : Legend Biotech Corporation, Q4 2023 Earnings Call, Mar 11, 2024